OrganiGram Releases Cannabis 2.0 Products To Medical Users
Like many Canadian cannabis companies, OrganiGram (TSX: OGI) (NASDAQ: OGI) has had a tough year, losing 75% of its value over 12 months and having to dip into the markets to raise cash.
Growing pains associated with Canadian cannabis legalization plagued OrganiGram's once-promising roll out of regulated cannabis products. Optimistic executives did not help manage investors' expectations.
Image Source: Getty Images
Source Fool.com
